S1628 Mirikizumab Demonstrates Long-Term Efficacy on Histological Resolution in the Phase 3, Multicenter, Open-Label VIVID-2 Extension Study
Year: 2025
Type: conference-abstract
Authors: Walter Reinisch, Vipul Jairath, Marijana Protic, Gert De Hertogh, Noam Harpaz, Tadakazu Hisamatsu, Geert R. D’Haens, Rish Pai, Nathan Morris, Rebecca Hozak, Guanglei Yu, Frederick Durand, Fernando Magro
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7111005922
Cites:
Cited by:
Related to: